Mitochondrial DNA defects and selective extraocular muscle involvement in CPEO

Area of Science:

• Mitochondrial Medicine
• Ophthalmology
• Genetics

Background:

• Chronic progressive external ophthalmoplegia (CPEO) is a key manifestation of mitochondrial diseases, often exclusively affecting extraocular muscles (EOMs).
• Understanding the mechanisms behind EOM selectivity in CPEO is crucial for disease management.

Purpose of the Study:

• To investigate the extent of mitochondrial dysfunction in EOMs compared to skeletal muscles in CPEO patients.
• To explore the histological and molecular genetic basis for preferential EOM involvement.

Main Methods:

• Studied 13 CPEO patients with various mitochondrial DNA (mtDNA) defects.
• Assessed mitochondrial enzyme function (COX/SDH histochemistry) in EOM and quadriceps muscle.
• Quantified mtDNA mutation load in single muscle fibers using real-time PCR and PCR-RFLP.

Main Results:

• CPEO patients with mtDNA deletions showed significantly higher COX-deficient fibers in EOM (41.6%) than skeletal muscle (13.7%).
• EOMs exhibited a lower threshold for COX deficiency compared to skeletal muscles in patients with mtDNA deletions.
• Patients with mtDNA point mutations had less severe ocular phenotypes and no significant difference in COX deficiency or mutational threshold between muscle groups.

Conclusions:

• Greater mitochondrial dysfunction and a lower mutational threshold in EOMs explain the selective muscle involvement in CPEO.
• Tissue-specific mechanisms likely contribute to the clonal expansion and expression of secondary mtDNA deletions in CPEO patients with nuclear defects.